Skip to main contentAI and Advanced
/
NH · NSEBSE SENSEX77,537.72+0.82%BSE |
NIFTY 5024,231.85+0.64%NSE |
NIFTY BANK57,495.9+0.45%NSE |
NIFTY IT30,673.05+0.79%NSE |
NIFTY AUTO29,301.75+0.40%NSE |
NIFTY FMCG47,863.25+0.82%NSE |
NIFTY PHARMA26,416+0.39%NSE |
NIFTY 50023,512.95+0.54%NSE |
NH
NSE · Equity shares · Healthcare Facilities9.00 · 0.50%
Narayana Hrudayalaya NH
NSE:INR 1,797
BSE:INR 1,881
Data quality and coveragePrice, company fundamentals and optional research feeds are tracked separately.
Headline priceLast market snapshot
Company fundamentalsStale · last-known data
Research sections9 of 9 availableMissing source values remain unavailable, never zero-filled.
AI analysis and Advanced tools for NH
Analysis, reports, chat and Advanced access use the same ShareKeyX account. The backend remains authoritative for roles, subscriptions, credits and permissions.
Snapshot
Price and key statistics
Reported and computed values remain separate; missing values are not converted to zero.
Previous closeINR 1,788
Day rangeINR 1,790 — INR 1,812.4
52-week rangeINR 1,589 — INR 2,093.3
Volume1.98 L
Market cap38,187.34
P/E48.71
Fundamental highlightsReported values unless marked as computed
Revenue (INR Cr)7,896.04
Net Income (INR Cr)805.6
Rev Growth (5 Year %)25.05
P/E Ratio48.71
EPS42.31
Research path: Interpret Narayana Hrudayalaya's snapshot alongside the wider market dashboard, the financial-statement research guide and the valuation-ratios field guide.
Validated OHLC
Interactive price chart
Crosshair, OHLCV tooltip, indicators, volume, zoom and pan use the same candle API as the advanced workspace.
NHNarayana Hrudayalaya1d · INR · NSE
Loading validated candles…
Auditable calculations
Daily technical summary
Calculated from validated daily candles. Descriptive research only.
Calculating technicals…
Indicators describe price behaviour and volatility; they are not a BUY, NEUTRAL or SELL recommendation.
Company reporting
Financial statements
IND AS · INR crore
| Metric | 2026 | 2025 | 2024 |
|---|---|---|---|
| Total Liabilities Shareholders' Equity | 12,474.4 | 7,265.03 | 5,624.58 |
| Accumulated Depreciation Total | -1,757.04 | -1,474.11 | -1,335.88 |
| Cash Equivalents | 31 | 160 | 52.91 |
| Other Liabilities Total | 260.08 | 239.39 | 237.41 |
| Accrued Expenses | 34.51 | 7.41 | 2.91 |
| Long Term Debt | 4,667.18 | 1,966.48 | 1,195.06 |
| Common Stock Total | 204.36 | 204.36 | 204.36 |
| Other Equity Total | 340.35 | 143.65 | 109.89 |
| Other Current Assets Total | 1,058.74 | 101.05 | 53.01 |
| Prepaid Expenses | 117.37 | 22.96 | 30.87 |
| Total Assets | 12,474.4 | 7,265.03 | 5,624.58 |
| Current Portof LT Debt/Capital Leases | 331.2 | 277.7 | 257.47 |
| Additional Paid-In Capital | 506.41 | 506.41 | 506.41 |
| Cash | 739.07 | 297.19 | 210.92 |
| Total Equity | 4,537.26 | 3,626.36 | 2,883.68 |
| Long Term Investments | 158.92 | 107.48 | 5.83 |
| Retained Earnings(Accumulated Deficit) | 3,487.4 | 2,773.05 | 2,064.13 |
| Treasury Stock-Common | -1.26 | -1.26 | -1.26 |
| Total Common Shares Outstanding | 20.31 | 20.31 | 20.31 |
| Property/Plant/Equipment Total-Gross | 7,396.14 | 5,583.59 | 4,252.42 |
| Tangible Book Valueper Share Common Eq | 102.84 | 166.58 | 129.63 |
| Goodwill Net | 1,390.56 | 118.93 | 117.92 |
| Total Liabilities | 7,937.15 | 3,638.67 | 2,740.9 |
| Total Debt | 5,857.5 | 2,428.37 | 1,626.69 |
| Short Term Investments | 748.75 | 1,150.58 | 972.98 |
| Cashand Short Term Investments | 1,518.81 | 1,607.77 | 1,236.81 |
| Total Receivables Net | 1,015.51 | 660 | 485.61 |
| Notes Payable/Short Term Debt | 9.49 | 10.02 | 24.58 |
| Deferred Income Tax | 330.75 | 63.61 | 47.06 |
| Accounts Receivable-Trade Net | 982.36 | 623.74 | 480.94 |
| Property/Plant/Equipment Total-Net | 5,639.1 | 4,109.49 | 2,916.54 |
| Minority Interest | 2.26 | 1.88 | 1.41 |
| Total Current Liabilities | 1,827.25 | 1,193.14 | 1,110.38 |
| Total Inventory | 221.7 | 158.06 | 139.77 |
| ESOP Debt Guarantee | 0 | 0.15 | 0.15 |
| Accounts Payable | 1,032.11 | 574.45 | 603.57 |
| Other Currentliabilities Total | 419.94 | 323.55 | 221.86 |
| Total Long Term Debt | 5,516.8 | 2,140.64 | 1,344.65 |
| Intangibles Net | 1,058.11 | 124.26 | 132.9 |
| Other Long Term Assets Total | 112.26 | 92.51 | 72.59 |
| Note Receivable-Long Term | 183.33 | 162.52 | 432.74 |
| Total Current Assets | 3,932.14 | 2,549.84 | 1,946.06 |
| Capital Lease Obligations | 849.62 | 174.16 | 149.59 |
Fundamentals
Valuation and ratios
Valuation
PEG Ratio4.66
Price to Sale Ratio4.84
Growth
Debt 5Yr CAGR %47.97
Margins
Operating Margin 12m12.99
Operating Margin 5y Avg16.27
Net Profit Margin 12m9.06
Net Profit Margin 5y12.59
Yield
Dividend Yield %0.24
Risk and consensus
Source-qualified signals
Risk metrics
Overall RiskBalanced risk
Board Risk29.25
Analyst consensus
ConsensusBuy
Consensus score2.00
Analyst opinions10
Strong Sell count0
Sell count1
Hold count0
Buy count7
Strong Buy count2
Provider consensus uses a 1 (Strong Buy) to 5 (Strong Sell) score. The payload does not include price targets, so none are inferred from 52-week prices or recommendation percentages.Industry context
Peer comparison
Only peers present in the company profile payload are displayed.
| Company | Price | Market cap | P/E | Research |
|---|---|---|---|---|
| Apollo Hospitals Enterprise | INR 8,812.9 | 1.27 L | 64.93 | — |
| Max Healthcare Institute | INR 1,075 | 1.05 L | 71.47 | — |
| Fortis Healthcare | INR 935 | 70,588.59 | 67.89 | — |
| Aster DM Healthcare | INR 844.4 | 44,157.18 | 102.55 | — |
| Global Health | INR 1,440.1 | 38,871.79 | 63.65 | — |
Shareholding
Ownership
- Promoter
- 63.27%
- FII
- 9.40%
- MF
- 7.34%
- Other
- 19.99%
Company intelligence
Latest relevant news
Source, timestamp and external destination are shown. Provider relevance scores are not available.
Narayana Hrudayalaya Ltd Shows Signs of Mild Bullish Momentum Amid Technical Shifts - Markets MojoMarket news · 4 Jun 2026, 8:32 am
Narayana Hrudayalaya Ltd Shows Signs of Mild Bullish Momentum Amid Technical Shifts Markets Mojo
Narayana Hrudayalaya Ltd Valuation Shifts Signal Fair Price Amid Sector Dynamics - Markets MojoMarket news · 4 Jun 2026, 12:31 am
Narayana Hrudayalaya Ltd Valuation Shifts Signal Fair Price Amid Sector Dynamics Markets Mojo
Narayana Hrudayalaya Ltd is Rated Hold - Markets MojoMarket news · 3 Jun 2026, 10:36 am
Narayana Hrudayalaya Ltd is Rated Hold Markets Mojo
Narayana Hrudayalaya Ltd Valuation Shifts Signal Renewed Price Attractiveness - Markets MojoMarket news · 3 Jun 2026, 2:10 am
Narayana Hrudayalaya Ltd Valuation Shifts Signal Renewed Price Attractiveness Markets Mojo
Narayana Hrudayalaya India margins rise to 25.1% in Q4FY26 - scanx.tradeMarket news · 2 Jun 2026, 12:30 pm
Narayana Hrudayalaya India margins rise to 25.1% in Q4FY26 scanx.trade
Stock Radar: Narayana Hrudayalaya stock breaks out from inverse head & shoulder pattern; time to buy? - The Economic TimesMarket news · 27 May 2026, 12:30 pm
Stock Radar: Narayana Hrudayalaya stock breaks out from inverse head & shoulder pattern; time to buy? The Economic Times
Corporate actions
Events
- annual General MeetingAGM
- board MeetingsQuarterly Results
- dividendRs.4.5000 per share(45%)Final Dividend
- board MeetingsAudited Results & Final Dividend
- annual General MeetingCOM
- board MeetingsQuarterly Results
- annual General MeetingCOM
- board MeetingsQuarterly Results
ShareKeyX Community
Discussion and sentiment for Narayana Hrudayalaya
Posts are linked to the canonical company record. Community BUY, NEUTRAL and SELL opinions are user-generated, moderated and separate from analyst consensus and ShareKeyX AI.
Checking your ShareKeyX account…
Company profile
Business information
What the company does
Narayana Hrudayalaya Limited is engaged in medical and healthcare services. The Company operates a network of multispecialty and super-specialty hospitals across multiple locations. Its operating segment is Medical and Healthcare Related Services. Its medical services include anesthesiology, audiology, breast oncology and oncoplastic surgery, clinical psychology, congenital adult heart disease, cardiac sciences, developmental and behavioral pediatrics, endocrinology and diabetology, gastrointestinal oncology, gynecologic oncology, hepatology and liver transplantation, interventional and endovascular radiology, medical gastroenterology, neuro rehabilitation, pediatric hematology oncology, speech and swallow rehabilitation, thoracic and vascular surgery, vascular and endovascular surgery, surgical gastroenterology, and surgical oncology, among others. It has a network of over 18 hospitals and three heart centers across India, along with an international presence in the Cayman Islands.
Company facts
- Industry
- Healthcare Facilities
- Sector
- Healthcare Facilities
- NSE Code
- NH
- BSE Code
- 539551
Questions
Stock FAQ
What is the symbol and ISIN of Narayana Hrudayalaya?
Narayana Hrudayalaya has the symbol NH and ISIN - INE410P01011.
What is the current price of Narayana Hrudayalaya?
Narayana Hrudayalaya is currently trading at INR 1,797.00.
What are the year high and year low of Narayana Hrudayalaya?
Narayana Hrudayalaya has a year high of INR 2,093.30 and a year low of INR 1,589.00.
What is the market capitalization of Narayana Hrudayalaya?
Narayana Hrudayalaya has a market capitalization of INR 38,187.34 crore.
What is the P/E ratio of Narayana Hrudayalaya?
Narayana Hrudayalaya has a P/E ratio of 48.71.
What is the dividend yield of Narayana Hrudayalaya?
Narayana Hrudayalaya has a dividend yield of 0.24%.
How is the financial performance of Narayana Hrudayalaya based on revenue, net income, and EPS?
Narayana Hrudayalaya has revenue of INR 7,896.04 crore, net income of INR 805.60 crore, and EPS of INR 42.63.
What is the book value of Narayana Hrudayalaya?
Narayana Hrudayalaya has a book value of NA.
What is the debt-to-equity ratio of Narayana Hrudayalaya?
Narayana Hrudayalaya has a debt-to-equity ratio of NA.
What are the price-to-book and price-to-sales ratios of Narayana Hrudayalaya?
Narayana Hrudayalaya has a price-to-book ratio of NA and a price-to-sales ratio of 4.84.
Corporate-action adjustment is provider-defined. ShareKeyX research and computed indicators are not investment advice.